Sofosbuvir with peginterferon-ribavirin for 12 weeks in previously treated patients with hepatitis C genotype 2 or 3 and cirrhosis
出版年份 2015 全文链接
标题
Sofosbuvir with peginterferon-ribavirin for 12 weeks in previously treated patients with hepatitis C genotype 2 or 3 and cirrhosis
作者
关键词
-
出版物
HEPATOLOGY
Volume 61, Issue 3, Pages 769-775
出版商
Wiley
发表日期
2014-10-17
DOI
10.1002/hep.27567
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Infrequent Development of Resistance in Genotype 1–6 Hepatitis C Virus–Infected Subjects Treated With Sofosbuvir in Phase 2 and 3 Clinical Trials
- (2014) Evguenia S. Svarovskaia et al. CLINICAL INFECTIOUS DISEASES
- HCV genotype 3 is associated with an increased risk of cirrhosis and hepatocellular cancer in a national sample of U.S. Veterans with HCV
- (2014) Fasiha Kanwal et al. HEPATOLOGY
- Global epidemiology and genotype distribution of the hepatitis C virus infection
- (2014) Erin Gower et al. JOURNAL OF HEPATOLOGY
- Sofosbuvir and Ribavirin in HCV Genotypes 2 and 3
- (2014) Stefan Zeuzem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Durability of a sustained virological response, late clinical sequelae, and long-term changes in aspartate aminotransferase to the platelet ratio index after successful treatment with peginterferon/ribavirin for chronic hepatitis C
- (2013) Vasilios Papastergiou et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Is genotype 3 of the hepatitis C virus the new villain?
- (2013) Nicolas Goossens et al. HEPATOLOGY
- EASL Clinical Practice Guidelines: Management of hepatitis C virus infection
- (2013) JOURNAL OF HEPATOLOGY
- Is 3 the new 1: perspectives on virology, natural history and treatment for hepatitis C genotype 3
- (2013) E. B. Tapper et al. JOURNAL OF VIRAL HEPATITIS
- Sofosbuvir in combination with peginterferon alfa-2a and ribavirin for non-cirrhotic, treatment-naive patients with genotypes 1, 2, and 3 hepatitis C infection: a randomised, double-blind, phase 2 trial
- (2013) Eric Lawitz et al. LANCET INFECTIOUS DISEASES
- Sofosbuvir for Hepatitis C Genotype 2 or 3 in Patients without Treatment Options
- (2013) Ira M. Jacobson et al. NEW ENGLAND JOURNAL OF MEDICINE
- Nucleotide Polymerase Inhibitor Sofosbuvir plus Ribavirin for Hepatitis C
- (2013) Edward J. Gane et al. NEW ENGLAND JOURNAL OF MEDICINE
- Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
- (2013) Eric Lawitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- New Pharmacotherapy for Hepatitis C
- (2012) D N Assis et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- Hepatitis C virus directly acting antivirals: current developments with NS3/4A HCV serine protease inhibitors
- (2010) S. Naggie et al. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY
- Peginterferon alfa-2b and Ribavirin: Effective in Patients With Hepatitis C Who Failed Interferon alfa/Ribavirin Therapy
- (2009) Thierry Poynard et al. GASTROENTEROLOGY
- Diagnosis, management, and treatment of hepatitis C: An update
- (2008) Marc G. Ghany et al. HEPATOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started